Navigation Links
InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
Date:12/4/2012

ntees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), includ
'/>"/>
SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
9. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
10. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
11. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 Breckenridge Pharmaceutical, Inc. announced today ... MSN Laboratories Pvt. Ltd. ( Hyderabad, India ... several new ANDAs.  Under the terms of the agreement, ... to Breckenridge for the U.S. market, and Breckenridge will ... and MSN have agreed to develop an oral antibiotic ...
(Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
(Date:12/19/2014)... 2014 Research and Markets ( ... "Micro Market Monitor: North American Dermatology Diagnostic ... http://photos.prnewswire.com/prnh/20130307/600769 ... which has resulted in fueling the overall demand ... purpose of these dermatology devices is to assist ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... Feb. 17 Northwest,Biotherapeutics, Inc. (OTC Bulletin Board: ... today announced further long-term follow-up data, for the,second ... and Phase I/II clinical trials,with DCVax(R)-Brain in patients ... of brain cancer. During the update period from ...
... of eleven wounds healed in 6 weeks or lessPRINCETON, ... (OTC Bulletin Board: DSCI ), a provider of ... Dressings were the focus of a case series on ... previously failed to heal while being managed with such ...
Cached Medicine Technology:Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival 2Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival 3Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival 4Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival 5MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series 2MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series 3
(Date:12/19/2014)... Sweetdressy.com , a leading wedding dress ... selection of cheap prom dresses for ladies worldwide. The ... world and clients can buy these dresses at the ... feature cool cuts and delicate craftsmanship, and most of ... market. Discount shipping costs are available for all of ...
(Date:12/19/2014)... Energy Textiles is excited to announce ... the world’s leading responsive textile, can now be ... are a number of benefits to wearing Celliant, ... balanced body temperature; which can lead to enhanced ... athletic performance; and overall wellness. In addition, the ...
(Date:12/19/2014)... Branson, Missouri (PRWEB) December 19, 2014 ... a new official world record -- for the first time ... most prestigious record book, Guinness World Records 2015, listing the ... Steepest Wooden Roller Coaster. In additional awards announced this week, ... to See Christmas Lights in the US,” USA Today’s 10Best ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles ... state’s largest lake with more than 600 miles of ... a little more than 3,000 residents, hosted its annual ... 6th of December. , Featuring Santa, Christmas lights and ... on Main Street. Narconon Arrowhead’s parade float participated ...
(Date:12/19/2014)... dress is perfect for any occasion and is a vital ... has unveiled its new selection of evening dresses. Faddish clients ... Customers can view more at its website. , ... and praised by customers for many years. It focuses on ... order to expand its market share, the company has opened ...
Breaking Medicine News(10 mins):Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2
... new study suggests that blocking cancer cells, access to ... the most common and deadly form of brain cancer, ... appropriate for tumors with a hyperactive PI3K signaling pathway, ... cases. , Researchers at the Ohio State University Comprehensive ...
... UCLA researchers have found that the hormone estrogen may help ... affects 2 to 3 million individuals in the U.S., mostly ... The condition causes a progressive increase in blood pressure in ... ventricle and delivers blood to the lungs. The rise in ...
... Clinic have received a grant from the National Institutes of ... test that conclusively identifies concussions in college football players. ... after a game searches for a biomarker known as ... in an athlete,s blood. Damir Janigro, Ph.D., and Nicola ...
... Gardner HealthDay Reporter , THURSDAY, Sept. 15 (HealthDay News) ... may or may not be a sign of more serious ... train of thought or forgetting where you placed your keys may ... But having trouble remembering what happened a few minutes ago, or ...
... THURSDAY, Sept. 15 (HealthDay News) -- Drinking heavily may increase ... warn. When cigarettes are involved the risk of ... however, some victims died needlessly and could have survived had ... the team analyzed coroners, records for 95 fire victims in ...
... Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and ... its Stanley S. Scott Cancer Center, has found that a ... breast cancer cells. The research will be published September 14, ... Institute . Building upon Dr. Alahari,s earlier discovery of ...
Cached Medicine News:Health News:Starving cancer cells of cholesterol might offer a new way to treat brain tumors 2Health News:Estrogen treatment may help reverse severe pulmonary hypertension 2Health News:Estrogen treatment may help reverse severe pulmonary hypertension 3Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 2Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 3Health News:Certain 'Senior Moments' May Signal Mental Decline 2Health News:Certain 'Senior Moments' May Signal Mental Decline 3Health News:Heavy Drinking Ups Odds of Death in House Fire 2Health News:Protein discovered at LSUHSC may suppress breast cancer growth 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: